Valeant reports better-than-expected profit, raises forecast
October 20, 2014 at 08:15 AM EDT
Canada's Valeant Pharmaceuticals International Inc (NYSE:VRX), embroiled in a bitter fight to take over Botox maker Allergan Inc (NYSE:AGN), posted a better-than-expected quarterly profit, driven by demand for its skin, neuro and eye drugs.
